Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group

S Daenen; Ronnie van der Holt; GEG Verhoef; Bob Löwenberg; PW Wijermans; PC Huijgens; M van Marwijk Kooy; HC Schouten; MHH Kramer; A Ferrant; E van den Berg; MMC Steijaert; LF Verdonck; Pieter Sonneveld

doi:10.1016/j.leukres.2004.03.001

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group

S Daenen, Ronnie van der Holt, GEG Verhoef, Bob Löwenberg, PW Wijermans, PC Huijgens, M van Marwijk Kooy, HC Schouten, MHH Kramer, A Ferrant, E van den Berg, MMC Steijaert, LF Verdonck, Pieter Sonneveld

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

37 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1057-1067
Number of pages	11
Journal	Leukemia Research
Volume	28
DOIs	https://doi.org/10.1016/j.leukres.2004.03.001
Publication status	Published - 2004

Access to Document

10.1016/j.leukres.2004.03.001

http://hdl.handle.net/1765/67948

Cite this

Daenen, S., van der Holt, R., Verhoef, GEG., Löwenberg, B., Wijermans, PW., Huijgens, PC., van Marwijk Kooy, M., Schouten, HC., Kramer, MHH., Ferrant, A., van den Berg, E., Steijaert, MMC., Verdonck, LF., & Sonneveld, P. (2004). Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group. Leukemia Research, 28, 1057-1067. https://doi.org/10.1016/j.leukres.2004.03.001

@article{132762265fc147a9a7a2fae25e9a80b3,

title = "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group",

author = "S Daenen and {van der Holt}, Ronnie and GEG Verhoef and Bob L{\"o}wenberg and PW Wijermans and PC Huijgens and {van Marwijk Kooy}, M and HC Schouten and MHH Kramer and A Ferrant and {van den Berg}, E and MMC Steijaert and LF Verdonck and Pieter Sonneveld",

year = "2004",

doi = "10.1016/j.leukres.2004.03.001",

language = "Undefined/Unknown",

volume = "28",

pages = "1057--1067",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

}

Daenen, S, van der Holt, R, Verhoef, GEG, Löwenberg, B, Wijermans, PW, Huijgens, PC, van Marwijk Kooy, M, Schouten, HC, Kramer, MHH, Ferrant, A, van den Berg, E, Steijaert, MMC, Verdonck, LF & Sonneveld, P 2004, 'Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group', Leukemia Research, vol. 28, pp. 1057-1067. https://doi.org/10.1016/j.leukres.2004.03.001

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group. / Daenen, S; van der Holt, Ronnie; Verhoef, GEG et al.

In: Leukemia Research, Vol. 28, 2004, p. 1057-1067.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group

AU - Daenen, S

AU - van der Holt, Ronnie

AU - Verhoef, GEG

AU - Löwenberg, Bob

AU - Wijermans, PW

AU - Huijgens, PC

AU - van Marwijk Kooy, M

AU - Schouten, HC

AU - Kramer, MHH

AU - Ferrant, A

AU - van den Berg, E

AU - Steijaert, MMC

AU - Verdonck, LF

AU - Sonneveld, Pieter

PY - 2004

Y1 - 2004

U2 - 10.1016/j.leukres.2004.03.001

DO - 10.1016/j.leukres.2004.03.001

M3 - Article

SN - 0145-2126

VL - 28

SP - 1057

EP - 1067

JO - Leukemia Research

JF - Leukemia Research

ER -

Daenen S, van der Holt R, Verhoef GEG, Löwenberg B, Wijermans PW, Huijgens PC et al. Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group. Leukemia Research. 2004;28:1057-1067. doi: 10.1016/j.leukres.2004.03.001